A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED)

• Status: Completed
• Trial end date: 2001-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the effect of montelukast compared to placebo in children during the spring allergic rhinitis season.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Montelukast

Criteria

Inclusion Criteria:

• Patient has a history of allergic rhinitis symptoms which flare up during the study season

• Patient is a non-smoker

• Patient is in otherwise good health

• Patient is able to chew a tablet

Exclusion Criteria:

• Patient is hospitalized

• Patient is pregnant or nursing mother, or <8 weeks post partum

• Patient and/or parent intend to move or vacation away from home during the trial

• Patient has had a major surgical procedure within 4 weeks of the prestudy visit

• Patient has been treated in an emergency room or hospitalized for asthma within 3 months prior to study

• Patient has an upper respiratory, eye, or sinus infection, or a history of any of these within 3 weeks prior to study

• Patient has a recent history of a psychiatric disorder or attention deficit hyperactivity disorder